2012Clinical LipidologyOpen access

Therapeutic potential of cyclodextrins in the treatment of Niemann–Pick type C disease

Benny Liu

Open full text 62 citations

Abstract

mice, neurodegeneration was completely prevented. This review will explore the pathophysiology of NPC disease and the use of 2HPBCD as a possible therapeutic modality.

About this research paper

What this paper is about

mice, neurodegeneration was completely prevented. This review will explore the pathophysiology of NPC disease and the use of 2HPBCD as a possible therapeutic modality.

Why it matters

OpenAlex reports 62 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

mice, neurodegeneration was completely prevented. This review will explore the pathophysiology of NPC disease and the use of 2HPBCD as a possible therapeutic modality.

Key concepts: NPC1, Neurodegeneration, Lysosomal storage disease, Niemann–Pick disease, type C, Niemann–Pick disease, Endosome, Disease, Lysosome

Related papers

Back to paper searchBrowse research topicsOriginal source
Therapeutic potential of cyclodextrins in the treatment of Niemann–Pick type C disease — Research Paper | ScholarLens